SAN FRANCISCO, CA, USA I June 20, 2025 I Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

--Structure Therapeutics Inc., a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late ...

The three presentations will also be presented during a poster session on Monday, June 9, 2025, from 5:00-7:00 PM EST. Additional details on the meeting can be found at IRSF’s website.

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3 rd-generation EGFR inhibitors and outperforms other investigational 4 th-generation inhibitors ...

CALDWELL – The Essex Photo Club has a busy schedule for the month of April. At 7:30 p.m. on Thursday, April 3 via Zoom, the club will have a presentation on pinhole analogue photography by ...

Fourth-grade students who participate in the Ag Sack Lunch program, whether in-person or virtually, hear a presentation about the importance of agriculture to Nebraska.